Family Medicine

Forrest General Hospital Program

Hattiesburg, MS · East South Central

No visa sponsorshipCategorical
YOUR FIT· Forrest General Hospital Program

Create a free profile to see your personalized fit

Get Started

Applicant Profile

2025 Data

What successful applicants at this program look like

See how competitive you are here

Compare your stats against applicants at Forrest General Hospital Program

Create Free Account

Contact

RR
Program Director
Rambod Rouhbakhsh, MD, MBA, BA
Email director
HL
Program Coordinator
Helon Lofton
Email coordinator

Training Sites

5 hospitals in Hattiesburg

  • 1
    Forrest General Hospital
    Hattiesburg, MS
    Primary
  • 2
    Southeast Mississippi Rural Health Initiative
    Hattiesburg, MS
    Participant
  • 3
    Wayne General Hospital
    Waynesboro, MS
    Participant
  • 4
    Lamar Healthcare and Rehabilitation Center
    Lumberton, MS
    Participant
  • 5
    Hattiesburg Clinic
    Hattiesburg, MS
    Participant

Score Ranges

USMLE Step 2 CK215251
180205230255280
COMLEX Level 2 CE408586
400500600700800

Interview Rates

US MD
64%
US DO
61%
US IMG
19%
Non-US IMG
0%

Applicant Origin

In-State
79%
Out-of-State
29%

Interview Prep

Common questions for Family Medicine interviews

specialtyWhat attracts you to the breadth of family medicine?★ common
programRural vs urban practice — what's your preference?
clinicalHow do you approach continuity of care?
specialtyTell me about procedures you'd like to incorporate into your practice.
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common

Community Resources

Family Medicine applicant community for 2025-2026 cycle

Calculate your match probability for Family Medicine

See how your profile compares across all programs

Open Calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.